Welcome to the latest update from Professional Affairs! This fall has been packed with major developments—from the release of Maximum Fair Prices for Medicare drugs to continued government focus of pharmacy benefit managers and much more.
On Feb. 26, the House Energy & Commerce Health Subcommittee held a hearing titled: "An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for Patients.“
